These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 25115631)
1. Expression of Neural Wiskott-Aldrich Syndrome Protein in Clear Cell Renal Cell Carcinoma and Its Correlation with Clinicopathological Features. Liu GH; Chen J; Ji ZG; Zhou L Urol Int; 2015; 95(1):79-85. PubMed ID: 25115631 [TBL] [Abstract][Full Text] [Related]
2. The expression of CFL1 and N-WASP in esophageal squamous cell carcinoma and its correlation with clinicopathological features. Wang WS; Zhong HJ; Xiao DW; Huang X; Liao LD; Xie ZF; Xu XE; Shen ZY; Xu LY; Li EM Dis Esophagus; 2010 Aug; 23(6):512-21. PubMed ID: 20095995 [TBL] [Abstract][Full Text] [Related]
3. Upregulation of COL6A1 is predictive of poor prognosis in clear cell renal cell carcinoma patients. Wan F; Wang H; Shen Y; Zhang H; Shi G; Zhu Y; Dai B; Ye D Oncotarget; 2015 Sep; 6(29):27378-87. PubMed ID: 26317545 [TBL] [Abstract][Full Text] [Related]
4. hZIP1 that is down-regulated in clear cell renal cell carcinoma is negatively associated with the malignant potential of the tumor. Dong X; Kong C; Zhang Z; Liu X; Zhan B; Chen Z; Shi D Urol Oncol; 2014 Aug; 32(6):885-92. PubMed ID: 24878177 [TBL] [Abstract][Full Text] [Related]
5. High expression of long non-coding RNA SPRY4-IT1 predicts poor prognosis of clear cell renal cell carcinoma. Zhang HM; Yang FQ; Yan Y; Che JP; Zheng JH Int J Clin Exp Pathol; 2014; 7(9):5801-9. PubMed ID: 25337221 [TBL] [Abstract][Full Text] [Related]
6. High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma. Lyu X; Li H; Ma X; Li X; Gao Y; Ni D; Shen D; Gu L; Wang B; Zhang Y; Zhang X Cell Biochem Biophys; 2015 Jan; 71(1):279-90. PubMed ID: 25120023 [TBL] [Abstract][Full Text] [Related]
7. Down-regulation of human leukocyte antigen class I (HLA-I) is associated with poor prognosis in patients with clear cell renal cell carcinoma. Yuan J; Liu S; Yu Q; Lin Y; Bi Y; Wang Y; An R Acta Histochem; 2013 Jun; 115(5):470-4. PubMed ID: 23245688 [TBL] [Abstract][Full Text] [Related]
8. High CLEC-2 expression associates with unfavorable postoperative prognosis of patients with clear cell renal cell carcinoma. Xiong Y; Liu L; Xia Y; Wang J; Xi W; Bai Q; Qu Y; Long Q; Xu J; Guo J Oncotarget; 2016 Sep; 7(39):63661-63668. PubMed ID: 27564117 [TBL] [Abstract][Full Text] [Related]
9. Decreased expression of CTR2 predicts poor prognosis of patients with clear cell renal cell carcinoma. Xia Y; Liu L; Long Q; Bai Q; Wang J; Xu J; Guo J Urol Oncol; 2016 Jan; 34(1):5.e1-9. PubMed ID: 26411550 [TBL] [Abstract][Full Text] [Related]
10. Reduced expression of growth and differentiation factor-9 (GDF9) is associated with aggressive behaviour of human clear-cell renal cell carcinoma and poor patient survival. Du P; Ye L; Yang Y; Jiang WG Anticancer Res; 2014 Nov; 34(11):6515-20. PubMed ID: 25368253 [TBL] [Abstract][Full Text] [Related]
11. Tumor VEGF expression correlates with tumor stage and identifies prognostically different groups in patients with clear cell renal cell carcinoma. Minardi D; Santoni M; Lucarini G; Mazzucchelli R; Burattini L; Conti A; Bianconi M; Scartozzi M; Milanese G; Primio RD; Montironi R; Cascinu S; Muzzonigro G Urol Oncol; 2015 Mar; 33(3):113.e1-7. PubMed ID: 25069421 [TBL] [Abstract][Full Text] [Related]
12. ITGA2B and ITGA8 are predictive of prognosis in clear cell renal cell carcinoma patients. Lu X; Wan F; Zhang H; Shi G; Ye D Tumour Biol; 2016 Jan; 37(1):253-62. PubMed ID: 26198048 [TBL] [Abstract][Full Text] [Related]
13. Significance of amyloid A immunoexpression in the prognosis of renal cell carcinoma. Oz Atalay F; Aytac Vuruskan B; Vuruskan H APMIS; 2016 Apr; 124(4):257-62. PubMed ID: 26750935 [TBL] [Abstract][Full Text] [Related]
14. Dicer is down-regulated in clear cell renal cell carcinoma and in vitro Dicer knockdown enhances malignant phenotype transformation. Ma X; Fan Y; Gao Y; Zhang Y; Huang Q; Ai Q; Ni D; Chen W; Zhang P; Song E; Wang B; Shi T; Zheng T; Zhang X Urol Oncol; 2014 Jan; 32(1):46.e9-17. PubMed ID: 24094887 [TBL] [Abstract][Full Text] [Related]
15. PinX1 serves as a potential prognostic indicator for clear cell renal cell carcinoma and inhibits its invasion and metastasis by suppressing MMP-2 via NF-κB-dependent transcription. Li HL; Han L; Chen HR; Meng F; Liu QH; Pan ZQ; Bai J; Zheng JN Oncotarget; 2015 Aug; 6(25):21406-20. PubMed ID: 26033551 [TBL] [Abstract][Full Text] [Related]
16. ΑB-crystallin in clear cell renal cell carcinoma: tumor progression and prognostic significance. Ho PY; Chueh SC; Chiou SH; Wang SM; Lin WC; Lee IL; Yang HY; Peng HC; Lai MK Urol Oncol; 2013 Oct; 31(7):1367-77. PubMed ID: 22417627 [TBL] [Abstract][Full Text] [Related]
17. An increase in long non-coding RNA PANDAR is associated with poor prognosis in clear cell renal cell carcinoma. Xu Y; Tong Y; Zhu J; Lei Z; Wan L; Zhu X; Ye F; Xie L BMC Cancer; 2017 May; 17(1):373. PubMed ID: 28545465 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of FABP7 promotes cell growth and predicts poor prognosis of clear cell renal cell carcinoma. Zhou J; Deng Z; Chen Y; Gao Y; Wu D; Zhu G; Li L; Song W; Wang X; Wu K; He D Urol Oncol; 2015 Mar; 33(3):113.e9-17. PubMed ID: 25192834 [TBL] [Abstract][Full Text] [Related]
19. High expression of chemokine CCL2 is associated with recurrence after surgery in clear-cell renal cell carcinoma. Yang Y; Zhai C; Chang Y; Zhou L; Shi T; Tan C; Xu L; Xu J Urol Oncol; 2016 May; 34(5):238.e19-26. PubMed ID: 26749463 [TBL] [Abstract][Full Text] [Related]
20. Wiskott-Aldrich syndrome gene as a prognostic biomarker correlated with immune infiltrates in clear cell renal cell carcinoma. Ding G; Wang T; Liu S; Zhou Z; Ma J; Wu J Front Immunol; 2023; 14():1102824. PubMed ID: 37122750 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]